NCT04894188View on ClinicalTrials.gov

Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 27, 2022

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2041

Conditions
Prostate Cancer
Interventions
RADIATION

radiation therapy

Intensity modulated radiation therapy (IMRT), with 50 Gy in 25 daily fractions (2 Gy/fraction, 5 fractions weekly) for 5 weeks (week 1 - week 5).

DRUG

Goserelin 3.6 MG

Gosereline 3.6mg sc injection at week 1, week 5, and week 9

PROCEDURE

radical prostatectomy

Eligible patients will undergo robotic-assisted radical prostatectomy and pelvic lymph node dissection

Trial Locations (2)

Unknown

RECRUITING

National Taiwan University Hospital Yunlin Branch, Douliu City/Huwei Township

RECRUITING

National Taiwan University Hospital, Tapiei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER